Sad to see today’s press release…
ImmunityBio Reports Median Overall Survival Not Yet Reached and Lymphopenia Reversed in Recurrent Glioblastoma Patients
What are your thoughts? BUY on the DIP?
Or is it downhill from here?
Hold for life?
Technical analysis 🧐 only not speculation.